logo
Share SHARE
FONT-SIZE Plus   Neg

Illumina Advises Stockholders To Take No Action In Response To Roche's New Offer

Illumina, Inc. (ILMN) suggested that its stockholders take no action at this time in response to announcement by Roche Holding AG (RHHBY.PK) that it is now offering to acquire Illumina for $51.00 per share in cash.

Earlier, on February 7, 2012, Illumina's Board of Directors rejected Roche's $44.50 per share cash tender offer and recommended that stockholders not tender their shares.

Illumina stated that its Board of Directors will thoroughly review Roche's revised proposal and make a recommendation to stockholders regarding the proposal in due course.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
So far this year, 23 novel drugs have already received FDA approval. Now let's take a look at the biotech stocks waiting to hear from the FDA in July. President Donald Trump has continued his assault on one of his favorite targets on Wednesday, lashing out at major media outlets in a series of posts on Twitter. Trump singled out the New York Times and the Washington Post in his tweets, describing the newspapers as "fake news." Christoph, born on-board a Spirit flight destined to Dallas from Fort Lauderdale airport, can celebrate all his forthcoming birthdays in life with a free travel on Spirit airline.
comments powered by Disqus
Follow RTT